Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in Systemic Lupus Erythematosus.
Minji AiXian ZhouMichele CarrerPaymaan Jafar-NejadYanfeng LiNaomi Gades D V MMariam P AlexanderMario A BautistaAli A Duarte GarciaHu ZengPublished in: bioRxiv : the preprint server for biology (2024)
Targeting mTORC2 could be a promising therapeutic for SLE.